Next 10 |
2024-05-09 15:17:08 ET GlycoMimetics, Inc. (GLYC) Corporate Update Call May 06, 2024 08:30 AM ET Company Participants Christian Dinneen-Long - General Counsel Harout Semerjian - CEO Edwin Rock - Chief Medical Officer Conference Call Participants Tara ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
2024-05-08 11:20:25 ET More on GlycoMimetics GlycoMimetics: Is No News Bad News? GlycoMimetics, Inc. (GLYC) Q4 2023 Earnings Call Transcript GlycoMimetics Can Become A Game Changer In Blood Cancers GlycoMimetics plummets 77% as phase 3 leukemia therapy uprole...
A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 8.1% to $25.21 on volume of 141,121,870 shares Lyra Therapeutics Inc. (LYRA) fell 87.1% to $0.5215 on volume of 107,579,343 shares PROSHARES TRUST (SQQQ) fell 3.4% to $10.7 on volume of 9...
2024-05-06 13:17:53 ET More on Mid-day movers & stocks. Manitex International, Inc. 2024 Q1 - Results - Earnings Call Presentation Manitex International, Inc. (MNTX) Q1 2024 Earnings Call Transcript Manitex International, Inc. (MNTX) Q4 2023 Earnings Call Transcr...
2024-05-06 10:01:41 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...
A look at the top 10 most actives in the United States XBP Europe Holdings Inc. (XBP) rose 69.1% to $3.5846 on volume of 37,660,870 shares Lyra Therapeutics Inc. (LYRA) fell 90.2% to $0.3942 on volume of 21,985,500 shares NIO Inc. American depositary shares each representing one Class A (...
2024-05-06 08:39:50 ET More on GlycoMimetics GlycoMimetics: Is No News Bad News? GlycoMimetics, Inc. (GLYC) Q4 2023 Earnings Call Transcript GlycoMimetics Can Become A Game Changer In Blood Cancers Seeking Alpha’s Quant Rating on GlycoMimetics ...
2024-05-06 08:26:44 ET More on pre-market losers & stocks. GameStop: Approaching An Optimistic Fair Value But Not There Yet GameStop: Operations Are Stabilizing, But Expect More Pain To Come Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript ...
Study of uproleselan combined with chemotherapy did not meet its primary endpoint of overall survival in the intent to treat population Adverse events were consistent with known side effect profiles of chemotherapy used in the study Comprehensive data analysis with medical, statistical, a...
News, Short Squeeze, Breakout and More Instantly...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 38...
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 0.18% to 38,7...